HVA vs IA/DA or VA in the Treatment of ND HR-AML
HVA vs IA/DA or VA in the Treatment of ND HR-AML
Recruiting · NCT06810791 · Registry updated 2025-02-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HVA vs IA/DA or VA in the Treatment of ND HR-AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 3 | 2025-02-06 | NCT06810791 |
18 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Hematology,Nanfang Hospital, Southern Medical University | Guangzhou | China | 3 |